Pharmacy - Chemotherapy/Oncology News & Articles

181 Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA Anti-Cancer Drugs, June 5, 2013    Clinical Article

182 Phase I study of the combination of temsirolimus and pazopanib in advanced solid tumors Anti-Cancer Drugs, June 5, 2013    Clinical Article

183 Effect of Zileuton and Celecoxib on Urinary LTE4 and PGE-M Levels in Smokers Cancer Prevention Research, June 5, 2013    Clinical Article

184 Infections in pediatric acute promyelocytic leukemia: from the canadian infections in acute myeloid leukemia research group Full Text BMC Cancer, June 5, 2013    Clinical Article

185 Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines Cancer Chemotherapy and Pharmacology, June 5, 2013    Clinical Article

186 CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity Clinical Cancer Research, June 5, 2013    Clinical Article

187 Discordances in estrogen receptor status, progesterone receptor status, and her2 status between primary breast cancer and metastasis Full Text The Oncologist, June 5, 2013    Clinical Article

188 Impact of t(11;14)(q13;q32) on the outcome of autologous hematopoietic cell transplantation in multiple myeloma Biology of Blood and Marrow Transplantation, June 5, 2013    Clinical Article

189 Over-Expression of Mcl-1 Confers Multi-Drug Resistance While Topo IIβ Down-Regulation Introduces Mitoxantrone-Specific Drug Resistance in Acute Myeloid Leukemia Molecular Pharmacology, June 5, 2013    Clinical Article

190 Blockade of PI3K/AKT pathway enhances sensitivity of Raji cells to chemotherapy through down-regulation of HSP70 Cancer Cell International, June 5, 2013    Clinical Article

191 Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib International Journal of Hematology, June 5, 2013    Clinical Article

192 Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells Blood Cells, Molecules, and Diseases, June 5, 2013    Clinical Article

193 Metronomic therapy is an effective salvage treatment for heavily pretreated relapsed/refractory multiple myeloma Full Text Haematologica, June 4, 2013    Clinical Article

194 Axitinib for the treatment of advanced non-small-cell lung cancer Expert Opinion on Investigational Drugs, June 4, 2013    Clinical Article

195 Effects of dextran-40 on flap viability after modified radical mastectomy Canadian Journal of Plastic Surgery, June 4, 2013    Clinical Article

196 Vismodegib for the treatment of basal cell skin cancer American Journal of Health-System Pharmacy, June 4, 2013    Review Article

197 Crizotinib versus chemotherapy in advanced ALK-positive lung cancer New England Journal of Medicine, June 4, 2013    Evidence Based Medicine    Clinical Article

198 Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study Full Text BMC Cancer, June 4, 2013    Clinical Article

199 Incidence of chemotherapy-induced neutropenia and current practice of prophylaxis with granulocyte colony-stimulating factors in cancer patients in Spain: a prospective, observational study European Journal of Cancer Care, June 4, 2013    Clinical Article

200 Molecularly targeted therapies for nonmelanoma skin cancers International Journal of Dermatology, June 4, 2013    Review Article

1 All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer Cancer Chemotherapy and Pharmacology, March 27, 2013

2 A phase II trial of neoadjuvant nab-paclitaxel, carboplatin, and gemcitabine (ACAG) in patients with locally advanced carcinoma of the bladder Urology, May 24, 2013

3 5-azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy American Journal of Hematology, April 29, 2013

4 Current opinion on optimal treatment for colorectal cancer Expert Review of Anticancer Therapy, May 13, 2013    Review Article

5 The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy Supportive Care in Cancer, May 3, 2013

6 Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy British Journal of Haematology, May 17, 2013

7 Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases Supportive Care in Cancer, May 3, 2013

8 Efficacy and cost of single-dose rasburicase in prevention and treatment of adult tumour lysis syndrome: a meta-analysis Journal of Clinical Pharmacy and Therapeutics, April 9, 2013    Evidence Based Medicine    Review Article

9 Feasibility and safety of dose-dense docetaxel after conventional epirubicin and cyclophosphamide as adjuvant treatment for early breast cancer patients The Breast, May 29, 2013

10 A randomized, phase II, three-arm study of two schedules of ixabepilone or paclitaxel plus bevacizumab as first-line therapy for metastatic breast cancer Breast Cancer Research and Treatment, May 7, 2013

11 Pain in outpatients treated for breast cancer: prevalence, pharmacological treatment, and impact on quality of life Cancer Nursing, May 10, 2013

12 Primary Granulocyte Colony-Stimulating Factor Prophylaxis During the First Two Cycles Only or Throughout All Chemotherapy Cycles in Patients With Breast Cancer at Risk for Febrile Neutropenia Journal of Clinical Oncology, May 2, 2013

13 Receipt of maintenance therapy is most predictive of survival in older acute lymphoblastic leukemia patients treated with intensive induction chemotherapy regimens American Journal of Hematology, May 3, 2013

14 Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis Breast Cancer Research and Treatment, April 17, 2013

15 Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer Breast Cancer Research and Treatment, May 21, 2013

16 Mechanism of impaired glucose metabolism during nilotinib therapy in patients with chronic myelogenous leukemia Haematologica, May 29, 2013    Free full text

17 Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma Leukemia, May 29, 2013

18 High-Dose Cytarabine Consolidation With or Without Additional Amsacrine and Mitoxantrone in Acute Myeloid Leukemia: Results of the Prospective Randomized AML2003 Trial Journal of Clinical Oncology, May 1, 2013

19 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 21, 2013

20 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 28, 2013